Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Completed 3 Active not recruiting 3 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Childhood Solid Tumor 1

Interventions

pembrolizumab 28 Carboplatin 13 Nivolumab 12 Cisplatin 12 atezolizumab 10 Paclitaxel 10 venetoclax 9 Ipilimumab 9 Radiotherapy 8 Pemetrexed 8 Docetaxel 8 fludarabine 7 durvalumab 7 Specimen Handling 7 Gemcitabine 7 Cyclophosphamide 7 Bevacizumab 7 fludarabine phosphate 6 Practice Guidelines as Topic 6 Cetuximab 6 Biopsy 6 tislelizumab 5 enzalutamide 5 Trastuzumab 5 Standard of Care 5 Radiosurgery 5 Magnetic Resonance Spectroscopy 5 Dexamethasone 5 Cytarabine 5 tazemetostat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Vinblastine × 90 days × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡